The mechanism of restenosis in bioresorbable vascular scaffold (BVS) may be different from that of metallic stents and it is still poorly investigated. Intravascular imaging techniques are useful tools for corroborating or excluding possible mechanisms of intra-scaffold restenosis. In these novel devices intravascular imaging should be systematically used for a better comprehension of the in-scaffold restenosis mechanism
Bioresorbable vascular scaffolds (BRS) are novel devices designed to provide transient vessel suppor...
The advent of intracoronary stents has greatly increased the safety and applicability of percutaneou...
Drug-eluting stents have reduced the risk of in-stent restenosis and have broadened the application ...
The mechanism of restenosis in bioresorbable vascular scaffold (BVS) may be different from that of m...
The mechanism of restenosis in bioresorbable vascular scaffold (BVS) may be different from that of m...
In the field of interventional cardiology, the era of vascular reparative therapy has started with t...
Treatment of in-stent restenosis (ISR) is still challenging. In this setting, the use of bioresorbab...
The management of patients with significant in-stent restenosis (ISR) with drug-eluting stent is sti...
In recent years, bioresorbable vascular scaffolds (BVS) have been introduced into clinical practice....
Bioresorbable vascular scaffolds (BRS) represent a novel approach for coronary revascularization off...
The Absorb bioresorbable vascular scaffold (Absorb BVS, Abbott Vascular, Santa Clara, California) pr...
markdownabstract__Abstract__ The pattern of vascular responses following stent/scaffold implantat...
Background: Bioresorption of bioresorbable vascular scaffold (BVS) may lead to late coronary lumen e...
Coronary in-stent restenosis (ISR) is a clinical problem for which a satisfactory solution has not b...
textabstractBackground - As bioresorbable vascular scaffolds (BVSs) are being increasingly used in c...
Bioresorbable vascular scaffolds (BRS) are novel devices designed to provide transient vessel suppor...
The advent of intracoronary stents has greatly increased the safety and applicability of percutaneou...
Drug-eluting stents have reduced the risk of in-stent restenosis and have broadened the application ...
The mechanism of restenosis in bioresorbable vascular scaffold (BVS) may be different from that of m...
The mechanism of restenosis in bioresorbable vascular scaffold (BVS) may be different from that of m...
In the field of interventional cardiology, the era of vascular reparative therapy has started with t...
Treatment of in-stent restenosis (ISR) is still challenging. In this setting, the use of bioresorbab...
The management of patients with significant in-stent restenosis (ISR) with drug-eluting stent is sti...
In recent years, bioresorbable vascular scaffolds (BVS) have been introduced into clinical practice....
Bioresorbable vascular scaffolds (BRS) represent a novel approach for coronary revascularization off...
The Absorb bioresorbable vascular scaffold (Absorb BVS, Abbott Vascular, Santa Clara, California) pr...
markdownabstract__Abstract__ The pattern of vascular responses following stent/scaffold implantat...
Background: Bioresorption of bioresorbable vascular scaffold (BVS) may lead to late coronary lumen e...
Coronary in-stent restenosis (ISR) is a clinical problem for which a satisfactory solution has not b...
textabstractBackground - As bioresorbable vascular scaffolds (BVSs) are being increasingly used in c...
Bioresorbable vascular scaffolds (BRS) are novel devices designed to provide transient vessel suppor...
The advent of intracoronary stents has greatly increased the safety and applicability of percutaneou...
Drug-eluting stents have reduced the risk of in-stent restenosis and have broadened the application ...